2-substituted benzimidazoles

Details for Australian Patent Application No. 2006260971 (hide)

Owner Tibotec Pharmaceuticals Ltd

Inventors Doublet, Frederic Marc Maurice; Fortin, Jerome Michel Claude; Muller, Philippe; Bonfanti, Jean-Francois

Agent Shelston IP

Pub. Number AU-B-2006260971

PCT Pub. Number WO2006/136563

Priority 05076440.6 20.06.05 EP

Filing date 20 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 15 September 2011

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4184 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 235/30 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136563 Priority application(s): WO2006/136563

15 September 2011 Application Accepted

  Published as AU-B-2006260971

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260975-Assembly of baffles and seals and method of assembling a heat exchanger

2006260970-Heterocyclylaminoalkyl substituted benzimidazoles